Key statistics dashboard for ResMed Inc. (RMD). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
Stock Data
| Price | $222.86 |
| Market Cap | $32.3B |
| Enterprise Value | $31.32B |
| Beta | 0.93 |
| Exchange | NYSE |
| Country | US |
Valuation Multiples
| P/E Ratio | 21.35 |
| Price / Book | 4.90 |
| P/S | 5.72 |
| EV/EBITDA | 14.59 |
| EV/Sales | 5.54 |
| EV/FCF | 10.84 |
| P/FCF | 11.19 |
| Earnings Yield | 4.78% |
| FCF Yield | 9.04% |
| Dividend Yield | 1.12% |
Profitability
| Gross Margin | 61.16% |
| EBIT Margin | 34.46% |
| EBITDA Margin | 37.96% |
| Operating Margin | 33.48% |
| Net Margin | 26.94% |
| Return on Equity | 23.88% |
| Return on Assets | 16.99% |
| Return on Invested Capital | 19.11% |
| Return on Capital Employed | 25.00% |
Financial Health
| Current Ratio | 3.10 |
| Quick Ratio | 2.42 |
| Cash Ratio | 1.05 |
| Debt / Equity | 0.13 |
| Debt / Assets | 9.21% |
| Net Debt / EBITDA | -0.30 |
| Interest Coverage | 65.20 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 9.96 |
Per-Share Data
| Revenue per share | 39.07 |
| Book Value per share | 45.51 |
| Cash per share | 10.15 |
| FCF per share | 19.97 |
| Tangible Book Value per share | 22.27 |
| Dividend per share | 2.46 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 14 |
| Hold | 16 |
| Sell | 5 |
| Strong Sell | 0 |
| Total analysts | 35 |
| Avg rating (1-5) | 0.26 |
Related companies: A · ALC · BDX · CAH · GEHC · HLN · HUM
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RMD: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks